利用脑膜炎球菌蛋白微阵列鉴定免疫原性外膜囊泡疫苗抗原组分
基于外膜囊泡(OMV)的疫苗已用于应对脑膜炎奈瑟菌引起的流行性脑膜炎疫情,但OMV成分复杂,难以鉴定保护性免疫应答相关抗原。本研究使用4CMenB(Bexsero)开放标签II期试验(NCT00962624)的人血清,在专用抗原微阵列上测量总IgG抗体结合谱,观察到针对OMV抗原中特定外膜蛋白(OMPs)的显著IgG应答,包括FetA、PorB、BamA和PorA。采用偏最小二乘回归将IgG抗体反应谱与人补体依赖性杀脑膜炎球菌活性相关联,表明该方法可有效鉴定OMV抗原(尤其是OpcA、FetA、PorA和PorB)对人疫苗接种者血清针对指示菌株的血清杀菌活性的潜在贡献,而血清杀菌活性是公认的侵袭性脑膜炎球菌病保护相关指标。
要点
- 4CMenB疫苗接种者血清对OMV抗原中FetA、PorB、BamA和PorA等外膜蛋白产生显著IgG应答。
- 偏最小二乘回归可将IgG抗体反应谱与人补体依赖性杀菌活性关联。
- 该方法可鉴定OpcA、FetA、PorA和PorB对血清杀菌活性的潜在贡献。
核心结论
- 该方法能有效鉴定OMV抗原(尤其是OpcA、FetA、PorA和PorB)对人疫苗接种者血清针对指示菌株的血清杀菌活性的潜在贡献。
研究设计与样本
- 研究使用4CMenB(Bexsero)开放标签II期试验(NCT00962624)的人血清,在专用抗原微阵列上测量总IgG抗体结合谱。
主要发现
- 观察到针对OMV抗原中特定外膜蛋白(OMPs)的显著IgG应答,包括FetA、PorB、BamA和PorA。
- 采用偏最小二乘回归将IgG抗体反应谱与人补体依赖性杀脑膜炎球菌活性相关联。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Outer membrane vesicle (OMV)-based vaccines have been employed worldwide in response to epidemic meningococcal disease outbreaks caused by Neisseria meningitidis. The complex composition of OMVs raises challenges in the identification of antigens which contribute to a protective immune response. Here, we measured total IgG antibody binding profiles to a dedicated antigen microarray using human sera from an open-label Phase II trial (NCT00962624) of 4CMenB (Bexsero), a licensed vaccine containing an OMV component. Significant IgG responses were observed against specific Outer Membrane Proteins (OMPs) from OMV antigens, including FetA, PorB, BamA and PorA. Partial Least Squares Regression was used to correlate IgG antibody reactivity profiles with the human complement-dependent killing of meningococci. We show that this approach is a powerful method to identify the potential contributions of OMV antigens - notably OpcA, FetA, PorA and PorB- towards serum bactericidal activity in human vaccinee serum against indicator strains, a recognised correlate of protection against invasive meningococcal disease.
引用
- Ramirez-Bencomo F, Thistlethwaite A, Viviani V, et al. Identification of immunogenic outer membrane vesicle vaccine antigen components using a meningococcal protein microarray. Vaccine. 2025. PMID: 40043411. doi:10.1016/j.vaccine.2025.126953
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。